Aug 6, 2026 08:33AM
Jul 10, 2026 06:52AM
Jul 8, 2026 12:30PM
Jul 8, 2026 11:32AM
Jul 8, 2026 08:00AM
Jun 29, 2026 06:47AM
Jun 22, 2026 08:02AM FDA grants RMAT designation to Prime Medicine's CGD therapy PM359
Jun 22, 2026 04:16AM
Jun 18, 2026 08:03AM
May 7, 2026 08:07AM
Mar 12, 2026 06:20AM
Mar 4, 2026 04:51AM
Dec 8, 2025 02:53AM
Nov 13, 2025 04:08AM Goldman Sachs Reiterates Early-Stage Biotech Rating on Prime Medicine (PRME)
Nov 7, 2025 04:27PM
Nov 7, 2025 08:10AM
Nov 3, 2025 08:01AM
Aug 13, 2025 07:09AM
Aug 8, 2025 04:22PM
Aug 7, 2025 08:37AM
Jul 21, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Prime Medicine (PRME)
Jul 17, 2025 06:49AM
Jul 16, 2025 07:01AM
Jun 18, 2025 04:47AM
Jun 18, 2025 04:45AM
May 27, 2025 03:49AM
May 20, 2025 04:12AM
May 19, 2025 04:22PM JPMorgan Downgrades Prime Medicine (PRME) to Neutral
May 19, 2025 01:12PM
May 19, 2025 10:37AM
May 19, 2025 10:28AM
May 19, 2025 08:32AM
May 8, 2025 05:02PM
Mar 20, 2025 06:28AM
Mar 19, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Prime Medicine (PRME)
Mar 19, 2025 04:12AM
Mar 18, 2025 07:01AM
Mar 4, 2025 04:34AM
Jan 6, 2025 10:35AM
Jan 3, 2025 01:22PM
Dec 20, 2024 12:46PM
Dec 13, 2024 08:21AM Prime Medicine (PRME) Files for 11M Share Offering by Selling Stockholders
Dec 10, 2024 03:18AM
Nov 13, 2024 06:26AM
Oct 25, 2024 06:19AM
Oct 15, 2024 08:02AM
Oct 4, 2024 07:19AM
Oct 2, 2024 06:44AM
Oct 1, 2024 07:35AM BMO Capital Reiterates Outperform Rating on Prime Medicine (PRME)
Sep 30, 2024 04:02PM

443,922 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All